Lung Non-Small Cell Carcinoma — Trials

Lung Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6,742 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,746
Recruiting: 924
Ph III recruiting: 138
Growth YoY: +3.3%
Industry share: 44%
Top sponsor: AstraZeneca
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,044)

clinicaltrialsPublishedShowing 1–50 of 367 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07005297	Clinical Genetics Branch Eligibility Screening Survey	not yet recruiting	—	1,000	National Cancer Institute (NCI)NIH	1	Sep 28, 2026	clinicaltrials
NCT07663630	A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss	not yet recruiting	Phase 1	80	PfizerINDUSTRY	2	Sep 25, 2026	clinicaltrials